IL6 and myasthenia gravis: Persistently elevated levels of IL-1β, IL-6 and TNF-α create a microenvironment that favors sustained immune activation, resulting in continuous autoantibody production, lymphocyte activation and tissue damage at the NMJ, which explains the chronic progressive nature of MG.